Claim being checked · Version 1 · Reviewed
“SS-31 and elamipretide are names for the same peptide.”
Written and source-checked by Anthony Treviso, founder of The Peptide Field.
No dosing advice. This guide explains research. It was not independently medically reviewed, and it does not diagnose, prescribe, or recommend treatment.
Supported with scope. The reviewed evidence supports this exact statement only in the situation described below.
Answer scope
This verdict checks the exact claim in the heading. It is not a universal grade for SS-31.
01 · Answer
Supported with scope
FDA's substance record lists SS-31 and elamipretide as synonyms. It also lists development names such as MTP-131 and Bendavia. A name match does not prove that an online vial has the same quality or product controls.
- What kind of evidence this is
- Regulatory or product record. This answer uses an official regulator record or a specific product label.
- What this answer covers
- FDA substance identity mapping; not a quality or product-equivalence finding. This answer covers only the named molecule and finished product. It also covers the product form and how people used it. The study limits include who took part, what was used for comparison, what changed, and how long the study lasted.
- Question type
- Mechanism and biomarkers. How a substance changed the body or a lab measurement. This may not show a health benefit.
02 · Sources
Read the sources behind this answer
- Editorial review
- Internal editorial review recorded
- Source review
- Anthony Treviso · Founder and responsible editor
- Medical review status
- Not independently medically reviewed. Editorial source review does not replace medical review.